The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.ae

Radiation recall pneumonitis

Publications

Onal C, Abali H, Koc Z, Kara S

Radiation recall pneumonitis caused by erlotinib after palliative definitive radiotherapy.

Onkologie 2012;35;191-4 — 2012 — 191-4

Togashi Y, Masago K, Mishima M, Fukudo M, Inui K

A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Jun;5;924-5 — 2010 Jun — 924-5